Clinical experience with beta-blockers in consultant psychiatric practice.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy*; D003863:Depression / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D006801:Humans; D008609:Mental Status Schedule; D010096:Oxprenolol / Q000627:therapeutic use; D010698:Phobic Disorders / Q000188:drug therapy; D011433:Propranolol / Q000627:therapeutic use; D011602:Psychophysiologic Disorders / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D010096:Oxprenolol; D011433:Propranolol